SEC Filing Summary for Derek Maetzold

Derek Maetzold, President and CEO of CASTLE BIOSCIENCES INC (CSTL), reported a series of transactions on June 15, 2026. He acquired 550 shares of Common Stock at $2.39 per share and disposed of 550 shares at a weighted-average price of $20.66. Additionally, numerous shares were disposed of indirectly through various trusts, including The Maetzold Descendants 2020 Trust, Derek Maetzold 2020 Irrevocable Trust, and The Maetzold 2018 Remainder Trusts. These transactions were executed under a Rule 10b5-1 plan. Maetzold also reported the disposal of 550 stock options. Following these transactions, his direct holdings amount to 22,029 shares, with indirect holdings in various trusts totaling over 100,000 shares.